Our next #RheumJC session will be Thursday, March 29th at 9pm Eastern Time / 8pm Central Time (click here to find this in your local time zone).
We’ll be discussing the recent New England Journal of Medicine article: Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
If you’re new to #RheumJC, take a look at our Intro to Twitter page or our Journal Club Getting Started Guide.
We strongly suggest using the website tchat.io as the best way to participate in the chat by typing in the #RheumJC hashtag to join the discussion.
As always:
- Please remember to try to stay on topic whenever possible.
- Be polite and courteous.
- Do not violate HIPAA.
We welcome suggestions for future articles for discussion. Please send your suggestions by Direct Message on Twitter to @RheumJC or email us at rheumjc@rheumjc.com.